1. Home
  2. MTEM vs SBFM Comparison

MTEM vs SBFM Comparison

Compare MTEM & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEM
  • SBFM
  • Stock Information
  • Founded
  • MTEM N/A
  • SBFM 2006
  • Country
  • MTEM United States
  • SBFM Canada
  • Employees
  • MTEM N/A
  • SBFM N/A
  • Industry
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEM Health Care
  • SBFM Health Care
  • Exchange
  • MTEM Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • MTEM 8.5M
  • SBFM 6.3M
  • IPO Year
  • MTEM N/A
  • SBFM N/A
  • Fundamental
  • Price
  • MTEM $1.36
  • SBFM $0.33
  • Analyst Decision
  • MTEM
  • SBFM Strong Buy
  • Analyst Count
  • MTEM 0
  • SBFM 1
  • Target Price
  • MTEM N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • MTEM 19.6K
  • SBFM 1.4M
  • Earning Date
  • MTEM 08-08-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • MTEM N/A
  • SBFM N/A
  • EPS Growth
  • MTEM N/A
  • SBFM N/A
  • EPS
  • MTEM N/A
  • SBFM N/A
  • Revenue
  • MTEM $31,763,000.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • MTEM N/A
  • SBFM $87.97
  • Revenue Next Year
  • MTEM N/A
  • SBFM $125.23
  • P/E Ratio
  • MTEM N/A
  • SBFM N/A
  • Revenue Growth
  • MTEM N/A
  • SBFM 193.30
  • 52 Week Low
  • MTEM $1.01
  • SBFM $0.28
  • 52 Week High
  • MTEM $9.45
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • MTEM 54.29
  • SBFM 34.58
  • Support Level
  • MTEM $1.26
  • SBFM $0.29
  • Resistance Level
  • MTEM $1.50
  • SBFM $0.32
  • Average True Range (ATR)
  • MTEM 0.11
  • SBFM 0.03
  • MACD
  • MTEM 0.01
  • SBFM 0.03
  • Stochastic Oscillator
  • MTEM 62.16
  • SBFM 17.85

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: